CYPHERPUNK TECHNOLOGIES INC. Comprehensive Income
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Comprehensive Income of $39.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-12
- CYPHERPUNK TECHNOLOGIES INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $39.39M.
- CYPHERPUNK TECHNOLOGIES INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$77.16M.
- CYPHERPUNK TECHNOLOGIES INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $40.21M.
- CYPHERPUNK TECHNOLOGIES INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$3.33M.
- CYPHERPUNK TECHNOLOGIES INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $4.85M.
- CYPHERPUNK TECHNOLOGIES INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$67.78M.
- CYPHERPUNK TECHNOLOGIES INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$81.44M.
- CYPHERPUNK TECHNOLOGIES INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$54.20M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $39.39M 10-Q · filed 2026-08-12 | -$37.76M 10-Q · filed 2026-08-12 | $2.45M derived: sum of 3 quarters · filed 2026-08-12 | -$876.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$77.16M 10-Q · filed 2026-05-14 | -$36.95M derived: sum of 2 quarters · filed 2026-05-14 | -$40.27M derived: sum of 3 quarters · filed 2026-05-14 | -$56.88M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $40.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $36.89M derived: sum of 2 quarters · filed 2026-03-16 | $20.27M derived: sum of 3 quarters · filed 2026-08-12 | $4.85M 10-K · filed 2026-03-16 |
| 2025-09-30 | -$3.33M 10-Q · filed 2025-11-12 | -$19.94M derived: sum of 2 quarters · filed 2026-08-12 | -$35.37M 10-Q · filed 2025-11-12 | -$50.92M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$16.61M 10-Q · filed 2026-08-12 | -$32.04M 10-Q · filed 2026-08-12 | -$47.60M derived: sum of 3 quarters · filed 2026-08-12 | -$65.77M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$15.43M 10-Q · filed 2026-05-14 | -$30.98M derived: sum of 2 quarters · filed 2026-05-14 | -$49.16M derived: sum of 3 quarters · filed 2026-05-14 | -$69.16M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$15.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$33.73M derived: sum of 2 quarters · filed 2026-03-16 | -$53.73M derived: sum of 3 quarters · filed 2026-03-16 | -$67.78M 10-K · filed 2026-03-16 |
| 2024-09-30 | -$18.17M 10-Q · filed 2025-11-12 | -$38.18M derived: sum of 2 quarters · filed 2025-11-12 | -$52.22M 10-Q · filed 2025-11-12 | -$65.34M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$20.00M 10-Q · filed 2025-08-14 | -$34.05M 10-Q · filed 2025-08-14 | -$47.17M derived: sum of 3 quarters · filed 2025-08-14 | -$60.52M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$14.05M 10-Q · filed 2025-05-13 | -$27.16M derived: sum of 2 quarters · filed 2025-05-13 | -$40.52M derived: sum of 3 quarters · filed 2025-05-13 | -$53.85M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$13.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$26.47M derived: sum of 2 quarters · filed 2025-03-26 | -$39.80M derived: sum of 3 quarters · filed 2025-03-26 | -$81.44M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$13.35M 10-Q · filed 2024-11-13 | -$26.68M derived: sum of 2 quarters · filed 2024-11-13 | -$68.32M 10-Q · filed 2024-11-13 | -$80.98M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$13.33M 10-Q · filed 2024-08-12 | -$54.97M 10-Q · filed 2024-08-12 | -$67.63M derived: sum of 3 quarters · filed 2024-08-12 | -$82.13M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$41.64M 10-Q · filed 2024-05-13 | -$54.30M derived: sum of 2 quarters · filed 2024-05-13 | -$68.80M derived: sum of 3 quarters · filed 2024-05-13 | -$85.30M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$12.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$27.16M derived: sum of 2 quarters · filed 2024-03-18 | -$43.67M derived: sum of 3 quarters · filed 2024-03-18 | -$54.20M 10-K · filed 2024-03-18 |
| 2022-09-30 | -$14.50M 10-Q · filed 2023-11-13 | -$31.00M derived: sum of 2 quarters · filed 2023-11-13 | -$41.54M 10-Q · filed 2023-11-13 | -$52.35M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$16.50M 10-Q · filed 2023-08-14 | -$27.04M 10-Q · filed 2023-08-14 | -$37.85M derived: sum of 3 quarters · filed 2023-08-14 | -$48.78M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$10.53M 10-Q · filed 2023-05-15 | -$21.34M derived: sum of 2 quarters · filed 2023-05-15 | -$32.28M derived: sum of 3 quarters · filed 2023-05-15 | -$41.69M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$10.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -$21.75M derived: sum of 2 quarters · filed 2023-03-24 | -$31.16M derived: sum of 3 quarters · filed 2023-03-24 | -$40.27M 10-K · filed 2023-03-24 |
| 2021-09-30 | -$10.94M 10-Q · filed 2022-11-14 | -$20.35M derived: sum of 2 quarters · filed 2022-11-14 | -$29.47M 10-Q · filed 2022-11-14 | -$36.67M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$9.41M 10-Q · filed 2022-08-12 | -$18.53M 10-Q · filed 2022-08-12 | -$25.73M derived: sum of 3 quarters · filed 2022-08-12 | -$33.00M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$9.12M 10-Q · filed 2022-05-13 | -$16.32M derived: sum of 2 quarters · filed 2022-05-13 | -$23.59M derived: sum of 3 quarters · filed 2022-05-13 | -$30.97M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$14.47M derived: sum of 2 quarters · filed 2022-03-11 | -$21.85M derived: sum of 3 quarters · filed 2022-03-11 | -$28.17M 10-K · filed 2022-03-11 |
| 2020-09-30 | -$7.26M 10-Q · filed 2021-11-12 | -$14.65M derived: sum of 2 quarters · filed 2021-11-12 | -$20.97M 10-Q · filed 2021-11-12 | -$29.21M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$7.38M 10-Q · filed 2021-08-13 | -$13.70M 10-Q · filed 2021-08-13 | -$21.95M derived: sum of 3 quarters · filed 2021-08-13 | -$29.88M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | -$6.32M 10-Q · filed 2021-05-14 | -$14.57M derived: sum of 2 quarters · filed 2021-05-14 | -$22.50M derived: sum of 3 quarters · filed 2021-05-14 | -$30.82M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | -$8.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$16.18M derived: sum of 2 quarters · filed 2021-03-12 | -$24.50M derived: sum of 3 quarters · filed 2021-03-12 | -$33.13M 10-K · filed 2021-03-12 |
| 2019-09-30 | -$7.93M 10-Q · filed 2020-11-12 | -$16.25M derived: sum of 2 quarters · filed 2020-11-12 | -$24.88M 10-Q · filed 2020-11-12 | -$23.26M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$8.32M 10-Q · filed 2020-08-13 | -$16.95M 10-Q · filed 2020-08-13 | -$15.33M derived: sum of 3 quarters · filed 2020-08-13 | -$21.78M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | -$8.63M 10-Q · filed 2020-05-14 | -$7.00M derived: sum of 2 quarters · filed 2020-05-14 | -$13.46M derived: sum of 3 quarters · filed 2020-05-14 | -$20.68M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$4.83M derived: sum of 2 quarters · filed 2020-03-16 | -$12.06M derived: sum of 3 quarters · filed 2020-03-16 | -$22.57M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$6.45M 10-Q · filed 2019-11-14 | -$13.68M derived: sum of 2 quarters · filed 2019-11-14 | -$24.19M 10-Q · filed 2019-11-14 | -$30.78M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$7.22M 10-Q · filed 2019-08-09 | -$17.74M 10-Q · filed 2019-08-09 | -$24.33M derived: sum of 3 quarters · filed 2019-08-09 | -$31.74M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | -$10.51M 10-Q · filed 2019-05-15 | -$17.10M derived: sum of 2 quarters · filed 2019-05-15 | -$24.52M derived: sum of 3 quarters · filed 2019-05-15 | -$30.99M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$6.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$14.01M derived: sum of 2 quarters · filed 2019-04-01 | -$20.48M derived: sum of 3 quarters · filed 2019-04-01 | -$30.29M 10-K · filed 2019-04-01 |
| 2017-09-30 | -$7.42M 10-Q · filed 2018-11-09 | -$13.88M derived: sum of 2 quarters · filed 2018-11-09 | -$23.70M 10-Q · filed 2018-11-09 | -$28.97M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | -$6.47M 10-Q · filed 2018-08-08 | -$16.28M 10-Q · filed 2018-08-08 | -$21.56M derived: sum of 3 quarters · filed 2018-08-08 | -$28.99M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | -$9.81M 10-Q/A · filed 2018-08-08 | -$15.09M derived: sum of 2 quarters · filed 2018-08-08 | -$22.52M derived: sum of 3 quarters · filed 2018-08-08 | -$29.99M derived: sum of 4 quarters · filed 2018-08-08 |
| 2016-12-31 | -$5.27M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$12.71M derived: sum of 2 quarters · filed 2018-02-23 | -$20.18M derived: sum of 3 quarters · filed 2018-02-23 | -$25.34M 10-K · filed 2018-02-23 |
| 2016-09-30 | -$7.43M 10-Q · filed 2017-11-13 | -$14.90M derived: sum of 2 quarters · filed 2017-11-13 | -$20.06M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$7.47M 10-Q · filed 2017-08-11 | -$12.63M 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | -$5.16M 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |